Lozartan Plus - winner of the tender for all dosages
In May and June 2018, the medicinal product Lozartan Plus LLC Lefpharm was awarded procurement contracts of the Republic of Belarus for all three dosages
JLLC «Lekpharm» on the Republican Board of Honor
For the achievement of the best indicators in the sphere of social and economic development among the organizations of industry in 2017, JLLC «Lekpharm» is listed on the Republican Board of Honor!
New drugs JLLC «Lekpharm»
Since the 1st quarter of 2018 JLLC «Lekpharm» implements new registered drugs
A new class of antihypertensive drugs from JLLC «Lekpharm»
In the first half of 2018 JLLC «Lekpharm» expanded the capabilities of doctors in the treatment of patients with cardiovascular diseases, mastering the release of drugs from the new class - antagonists of angiotensin II receptors (sartans)
Release of the third dosage in the line of the new drug - Bicard AM (bisoprolol / amlodipine)
JLLC «Lekpharm» informs health professionals about the release of the third dosage in the line of the new drug - Bicard AM (bisoprolol / amlodipine). The company mastered the release of tablets 5 mg / 10 mg № 30.
The Best Exporter of 2017
JLLC «Lekpharm» is awarded with the diploma of the republican contest «The Best Exporter of 2017»
Training "Merchandising and marketing communication in a pharmacy"
May 23-25, 2018 JLLS «Lekpharm» held a training course "Merchandising and marketing communication in a pharmacy"
Obtaining GMP certificate
JLLC «Lekpharm» received an international certificate of compliance of the site for the production of liquid medicines with GMP requirements, issued after the inspection of the PIC / S (Pharmaceutical Inspection Co-operation Scheme).